This session examines how genetic, genomic, epigenetic, and molecular variations influence immune function, disease susceptibility, treatment response, and clinical outcomes. It includes immune-related gene discovery, pharmacogenomics, personalized risk assessment, molecular classification, precision diagnostics, and individualized therapeutic strategies.
Abstract Scope and Participation
Abstracts may present genomic studies, biomarker research, patient stratification, computational analyses, rare disease findings, and clinical applications of precision medicine. The session welcomes immunologists, geneticists, clinicians, bioinformaticians, molecular scientists, laboratory professionals, and industry researchers working to advance personalized approaches in immune-mediated diseases.
Paulo Cesar De Morais
Catholic University of Brasília, Brazil
Francis J Castellino
University of Notre Dame, United States
Sergey Victorovich Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sergey Victorovich Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Francis J Castellino
University of Notre Dame, United States
Paulo Cesar De Morais
Catholic University of Brasília, BrazilSubmit your abstract Today
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Targeting tumor-associated antigens through variable epitope libraries: Antitumor activity in breast cancer and acute myeloid leukemia
Braulio Alejandro Martinez Zarco, UNAM, Mexico
Title : Ultra-low-dose methotrexate combined with low-dose prednisolone in two distinct chronic disorders: A hypothesis-generating clinical comparison
Naylya Djumaeva, Research Institute of Virology, Uzbekistan
Title : Treatment outcomes of adult Filipino patients with drug susceptible pulmonary and extrapulmonary tuberculosis after anti-Koch’s rechallenge regimen
Jizelle Kay Cofulan Fang Asan, Baguio General Hospital and Medical Center, Philippines
Title : Clinical, immunological, and cytokine profiles of primary Sjögren’s syndrome in a Western Algerian population
Ouikhlef Narjesse, EHU Oran & Faculty of Medicine of Oran, Algeria